Keith Publications Logo Keith Publications
  Cluster 3: Health, Medicine & Life Sciences

How to Publish Drug Research Papers (2026 Guide)

Drug research papers — covering everything from new compound synthesis and in vitro pharmacological profiling to clinical pharmacokinetics and post-marketing surveillance — require precise data reporting and compliance with ethical and reproducibility standards. This 2026 guide provides a step-by-step pathway for publishing drug research in Keith Publications pharmacology and biomedical journals, covering journal selection, manuscript structure, data requirements, and peer review navigation.

Submit Your Manuscript Browse All Topics

What to Look for When Choosing a Journal

Before submitting your research, evaluate journals on these key criteria:

  • Clear step-by-step submission process documented on the journal website
  • Author guidelines covering formatting, word count, referencing style, and figures
  • Transparent editorial workflow — know what happens after you submit
  • Reporting guidelines requirements clearly stated (CONSORT, STROBE, PRISMA, CARE)
  • Ethics and clinical trial registration requirements explicitly described
  • Responsive author support for questions before, during, and after submission

Recommended Journals — Cluster 3: Health, Medicine & Life Sciences

All journals below are published by Keith Publications — open access, peer-reviewed, and indexed for global discoverability.

  • Health Sciences and Medical Research Journal (HSMRJ)

    Health sciences, clinical medicine, public health, epidemiology, biomedical research, and interdisciplinary studies advancing human health outcomes.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Health Sciences Clinical Medicine Public Health Epidemiology
  • Columbia Journal of Medicine and Healthcare (CJMH)

    Medical research, healthcare delivery, hospital management, clinical practice, health policy, and translational medicine bridging research and patient care.

    Review: 2–3 weeks Open Access DOI (CrossRef) Google Scholar
    Medical Research Healthcare Delivery Clinical Practice Health Policy
  • Journal of Nursing and Allied Health Sciences (JNAHS)

    Nursing practice, allied health professions, patient care, clinical nursing research, health education, and evidence-based practice across healthcare settings.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Nursing Practice Allied Health Patient Care Health Education
  • Journal of Pharmacology and Biomedical Research (JPBR)

    Pharmacology, drug discovery, biomedical sciences, life sciences, oncology, biochemistry, and molecular medicine with clinical and applied relevance.

    Review: 2–4 weeks Open Access DOI (CrossRef) Google Scholar
    Pharmacology Drug Research Biomedical Sciences Life Sciences

Fast Publication: All Keith Publications journals complete initial review within 2–5 business days and full peer review within 2–4 weeks. Articles are published online within 5–10 days of acceptance — making us one of the fastest open access publishers in the health sciences and medicine field.

The Health Sciences Journal Publication Process — Step by Step

Publishing a health sciences research paper involves key stages: (1) Choose a journal with scope matching your research topic. (2) Read and follow the author guidelines precisely. (3) Ensure ethics approval is obtained and documented. (4) Register clinical trials before recruitment begins. (5) Prepare your manuscript following the appropriate reporting guideline (CONSORT, STROBE, CARE, PRISMA). (6) Submit through the online submission portal. (7) Await initial editorial screening (2–5 days at Keith Publications). (8) Undergo double-blind peer review (2–4 weeks). (9) Receive reviewer feedback — revise and resubmit if required. (10) Receive final acceptance. (11) Complete APC payment. (12) Article published online with DOI within 5–10 days.

Common Reasons Health Sciences Papers Are Rejected

Understanding why health papers are rejected helps you avoid common pitfalls. The most frequent rejection reasons are: (1) Scope mismatch — the topic does not fit the journal's stated aims. (2) Missing ethics approval — mandatory for all human participant research. (3) Insufficient originality — the paper does not make a clear new contribution. (4) Methodology weakness — study design, sample size, or statistical approach has significant flaws. (5) Failure to follow reporting guidelines (CONSORT, STROBE, etc.). (6) Missing clinical trial registration. (7) Poor abstract — does not clearly state problem, method, results, and significance. (8) Formatting non-compliance. Addressing all these before submission significantly increases your acceptance chances.

Tips to Maximise Your Acceptance Chances

  1. Align your topic with the journal's scope — read the aims and scope carefully before submitting.
  2. Write a compelling abstract — clearly state your research question, methodology, key findings, and clinical or scientific significance.
  3. Ensure ethical compliance — include ethics committee approval, patient consent, and clinical trial registration details where applicable.
  4. Follow reporting guidelines — use CONSORT, STROBE, CARE, PRISMA, or other relevant Equator Network standards for your study design.
  5. Use current and relevant references — cite recent publications alongside seminal works in your health sciences discipline.
  6. Follow formatting guidelines exactly — non-compliant manuscripts are often desk-rejected without peer review.
  7. State practical implications — explain how your health or medical findings can improve patient care or inform health policy.

Frequently Asked Questions

What are the steps for publishing a drug research paper?
Steps: (1) Complete your drug research — synthesis, characterisation, pharmacological profiling, or clinical study. (2) Obtain ethics approval for animal or human studies. (3) Choose the right pharmacology journal (JPBR for most drug research at Keith Publications). (4) Prepare your manuscript — compound data, experimental methods, results, statistical analysis. (5) Submit with all required documents including animal ethics approval and ARRIVE checklist or human ethics documentation. (6) Undergo peer review. (7) Revise based on reviewer feedback. (8) Accept and pay APC. (9) Published online with CrossRef DOI.
What compound characterisation data is required for new drug candidates?
For novel pharmacological compounds: full synthetic route with yield, 1H and 13C NMR spectra with assignments, IR spectrum, HRMS or LRMS data, melting point (for solids), HPLC purity (≥95%), logP or aqueous solubility data where available, and stability information. Missing characterisation data is a primary reason for rejection of medicinal chemistry and pharmacological compound papers.
How should I report IC50 and EC50 values in drug research papers?
Report IC50 or EC50 values with 95% confidence intervals from at least three independent experiments. Include the Hill coefficient for sigmoidal curves. Present full concentration-response curves (with error bars showing SEM or SD) rather than single concentration data points. State the software used for curve fitting (GraphPad Prism, R, etc.) and the equation used.
Do drug research papers require clinical translation discussion?
Yes. Even basic pharmacology papers should include a discussion section that addresses the clinical relevance and translational implications of the findings — even if just a brief paragraph. Reviewers and readers want to understand how your drug research contributes to potential clinical application, even at early preclinical stages.

Ready to Publish Your Research?

Submit your health sciences, medical, nursing, or life sciences manuscript to Keith Publications today. Fast peer review, open access, and global indexing — get your work published within weeks.

Submit Your Manuscript Now Contact the Editorial Team